Clinical Trial Update: Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating estradiol suppression for metastatic breast cancer in premenopausal women completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Stanford University | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-04-05